The Reproductive Infectious Diseases Program is a network of health professionals, researchers and knowledge users dedicated to advancing reproductive infectious diseases care and research internationally. Through local, national and global research collaborations, the team works to address emergent knowledge gaps and provide evidence-based guidance for the prevention, treatment, and care of reproductive infectious diseases. An overview of the program and the research we do can be found here

Latest Updates from the RID Program:

New Paper Published on Findings of RID Program’s COVERED Project!


A new paper authored by the team behind the RID Program’s COVERED Project has recently been published in the scientific journal Vaccine.

This paper, which can be found here, is entitled “Reactogenicity, pregnancy outcomes, and SARS-CoV-2 infection following COVID-19 vaccination during pregnancy in Canada: A national prospective cohort study“. The paper describes the findings from data collected from Canadian pregnant women and people from July 2021 to July 2022, to understand various aspects of their experience in pregnancy during the COVID-19 pandemic.

Take a look at this paper to see the fascinating insights found by the COVERED project, and if you find the study interesting and have become pregnant in 2023, consider joining the new iteration of the COVERED study which is currently recruiting! More information about participating can be found here!

The COVERED COVID-19 Vaccine Registry for 2023 pregnancies and its associated Immune Sub-Study are now open and accepting new participants!


The COVERED COVID-19 Vaccine Registry is a project conducted by the RID Program, which is aiming to increase knowledge surrounding vaccinations as well as maternal and infant outcomes for pregnant individuals across Canada.

This study is actively recruiting individuals across Canada who became pregnant in 2023 and are at least 19 years of age. No previous vaccination or intention to receive a vaccination is required to participate. If you are interested in participating, the e-consent for the study can be found here or for more information visit the COVERED website.

The COVERED Immune Sub-Study is recruiting currently pregnant people who are 19 years of age or older, intending or scheduled to be vaccinated against COVID-19, and registered to deliver at BC Women’s Hospital. This study involves collection of maternal blood samples, infant blood samples, and breast milk samples, in order to help understand the immune response to COVID-19 vaccines in pregnancy. If you are interested in participating or would like more information click here.

An interim report on recent findings from the CANCOVID-Preg Project has been released!


The newly released Report #6 addresses study data collected from 9 Canadian provinces & territories (BC, AB, MB, ON, QC, NB, NS, PE, YT) during the period of March 3rd, 2020 to December 31st, 2022 for the RID Program’s ongoing project CANCOVID-Preg.

This project is a pan-Canadian observational surveillance study on individuals who were infected with COVID-19 during pregnancy, to better understand the burden of COVID-19 infection in pregnancy in Canada as well as the associated maternal and infant/fetal outcomes for Canadian COVID-19-affected pregnancies.

This new report, which includes the data collected during the Omicron era, includes multiple new insights. Of note in this report, we observed a substantive decrease in complications during the Omicron era. Importantly, however, there remain higher rates of complications for unvaccinated versus vaccinated, suggesting that vaccination is still of great importance for our pregnant population.

To read the full report, please click here.